PubRank

Cevayir Coban

Author PubWeight™ 83.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005 18.32
2 A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2005 7.94
3 TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008 6.40
4 Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004 5.71
5 Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006 5.01
6 Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat Immunol 2006 4.15
7 Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008 4.14
8 Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 2007 3.14
9 Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med 2005 2.90
10 DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 2011 2.41
11 Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J Infect Dis 2009 1.65
12 Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 2011 1.65
13 Innate immune response to viral infection. Cytokine 2008 1.63
14 Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2010 1.46
15 TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur J Immunol 2005 1.36
16 Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol 2008 1.23
17 Manifold mechanisms of Toll-like receptor-ligand recognition. J Clin Immunol 2005 1.22
18 Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol 2010 1.04
19 CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+ monocytes. J Immunol 2005 1.03
20 Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist. Proc Natl Acad Sci U S A 2014 0.98
21 Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol 2006 0.97
22 The origins of African Plasmodium vivax; insights from mitochondrial genome sequencing. PLoS One 2011 0.96
23 Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol 2013 0.94
24 Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax. PLoS One 2011 0.93
25 Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism. Cell Host Microbe 2012 0.89
26 The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. Biomaterials 2010 0.88
27 Limited polymorphism of the Plasmodium vivax merozoite surface protein 1 gene in isolates from Turkey. Am J Trop Med Hyg 2010 0.87
28 Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am J Trop Med Hyg 2008 0.86
29 Raman spectroscopic analysis of malaria disease progression via blood and plasma samples. Analyst 2013 0.83
30 Innate immune control of nucleic acid-based vaccine immunogenicity. Expert Rev Vaccines 2009 0.83
31 Detection and size measurement of individual hemozoin nanocrystals in aquatic environment using a whispering gallery mode resonator. Opt Express 2012 0.81
32 A polysaccharide carrier to effectively deliver native phosphodiester CpG DNA to antigen-presenting cells. Bioconjug Chem 2007 0.81
33 The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant. PLoS One 2013 0.80
34 TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models. Hum Vaccin Immunother 2013 0.79
35 Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier. Bioconjug Chem 2006 0.75
36 Label-free Raman imaging of the macrophage response to the malaria pigment hemozoin. Analyst 2015 0.75